SCHEMBL8842875

SCHEMBL8842875

Nc1c(-c2cccc(C(F)(F)F)c2)n[nH]c1C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 2/20 0.48
ADORA1 P30542 2/20 0.48
IKBKB O14920 1/20 0.48
PIN1 Q13526 1/20 0.47
KMO O15229 2/20 0.47
PIM1 P11309 1/20 0.46
GRK6 P43250 1/20 0.46
NOTUM Q6P988 1/20 0.46
MAPK1 P28482 2/20 0.45
MAP2K4 P45985 2/20 0.45
MAPK6 Q16659 2/20 0.45
MAPKAPK3 Q16644 1/20 0.45
MAPKAPK5 Q8IW41 1/20 0.45
PARP1 P09874 1/20 0.44
XDH P47989 2/20 0.44
ALDH1A1 P00352 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
RORB Q92753 3/20 0.44
MAPK13 O15264 1/20 0.43
RAF1 P04049 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9403614 0.87 IKBKB (0.46) ADORA2AADORA1IKBKBPIN1PIM1
SCHEMBL8842891 0.86 PIN1 (0.47) ADORA2AADORA1IKBKBPIN1KMO
SCHEMBL23294713 0.82 PIN1 (0.48) ADORA2AADORA1PIN1KMOPIM1
SCHEMBL11073722 0.82 PIN1 (0.46) IKBKBPIN1KMOPIM1GRK6
SCHEMBL17966223 0.79 ALDH1A1 (0.59) PIN1MAPK1MAP2K4MAPK6MAPKAPK3
SCHEMBL2860093 0.75 MAP2K4 (0.71) KMOPIM1MAPK1MAP2K4MAPK6
SCHEMBL13734158 0.75 BRD4 (0.53) ADORA2AADORA1PIN1KMOXDH
Amflutizole SCHEMBL29400347 0.75 ALDH1A1 (0.52) ADORA2AADORA1PIN1KMOXDH
Amflutizole SCHEMBL395613 0.75 ALDH1A1 (0.52) ADORA2AADORA1PIN1KMOXDH
SCHEMBL11073721 0.74 MAPT (0.46) IKBKBPIN1PIM1NOTUMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5674887-A Prevention of bone resorption ELI LILLY AND COMPANY (US) 1997-10-07 US disclosed
EP-0578477-B1 Treatment of inflammatory bowel disease LILLY CO ELI (US) 1996-06-19 EP disclosed
US-5436258-A Prevention of bone resorption ELI LILLY AND COMPANY (US) 1995-07-25 US disclosed
EP-0587378-A1 Prevention of bone resorption ELI LILLY AND COMPANY (US) 1994-03-16 EP disclosed
US-5294630-A Treatment of inflammatory bowel disease ELI LILLY AND COMPANY (US) 1994-03-15 US disclosed
EP-0578477-A1 Treatment of inflammatory bowel disease ELI LILLY AND COMPANY (US) 1994-01-12 EP disclosed
US-4495195-A ANTI-GOUT, ANTI-GOUTY ARTHRITIS AGENTS ELI LILLY AND COMPANY (US) 1985-01-22 US disclosed
EP-0112623-A2 3-Aryl-5-pyrazole-carboxylic-acid derivatives, their preparation and pharmaceutical compositions ELI LILLY AND COMPANY (US) 1984-07-04 EP disclosed